Osteoporosis and fragility fractures are relevant health issues because of their impact in
terms of morbidity, mortality, and socioeconomic burden. Despite this alarming scenario …

Current osteoporosis medications reduce fractures significantly but have rare and serious
adverse effects (osteonecrosis of the jaw, atypical femoral fractures) that may limit their …

Introduction: Osteoporosis is a chronic, skeletal disorder characterized by compromised
bone strength and increased fracture risk; it affects 50% of women and 20% of men. In the …

Osteoporosis, a common chronic metabolic bone disease is associated with considerable
morbidity and mortality. As the prevalence of osteoporosis increases with age, a paralleled …

Although safe and effective agents are currently available to treat osteoporosis, fragility
fractures remain a significant problem worldwide. Recent improvements in the …

Purpose The incidence of osteoporosis-related fractures will increase substantially over the
coming decades as the population ages globally. This has important economic and public …

Osteoporosis is the most common bone disease affecting millions of people worldwide,
particularly in elderly or in post-menopausal women. The pathogenesis is useful to …

Future therapeutic targets in osteoporosis : Current Opinion in Rheumatology Future therapeutic
targets in osteoporosis : Current Opinion in Rheumatology Log in or Register Subscribe to …

Osteoporosis is a common disease that affects millions of patients worldwide and is most
common in menopausal women. The main characteristics of osteoporosis are low bone …

Osteoporosis is a skeletal disorder that causes impairment of bone structure and strength,
leading to a progressively increased risk of fragility fractures. The global prevalence of …